Serological and vaccine evaluation for hepatitis B among Community Health Workers
Abstract Objective: to identify the vaccination and serological status against hepatitis B among community health workers; to vaccinate against hepatitis B virus and to evaluate the immune response of susceptible workers. Method: phase I, cross-sectional and descriptive study, among community health workers in a capital city of the Midwest region, through a self-administered questionnaire, checking of vaccination cards, and blood collection for testing of serological markers for hepatitis B. Phase II, cohort study carried out in vaccinated non-immune workers identified in phase I. They received one dose of vaccine (challenge dose) and serological testing. Results: a total of 109 workers participated in the study. Most had vaccination record (97; 89.0%) and vaccination completeness (75; 77.3%), while the isolated anti-HBs (Antibodies against hepatitis B virus) marker was detected in 78 (71.6%) workers. The prevalence of hepatitis B virus exposure was 8.2%. Of the ten non-immune vaccinated workers, after challenge dose, one remained susceptible. Conclusion: although most workers are vaccinated and show immunological response to hepatitis B, susceptibility after challenge dose was identified. Therefore, it is necessary to have a surveillance program of the vaccination situation and serological status for this virus, to promote these workers’ safety..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
|---|---|
| Enthalten in: |
Revista Latino-Americana de Enfermagem - 31(2023) |
| Sprache: |
Englisch ; Spanisch ; Portugiesisch |
|---|
| Beteiligte Personen: |
Tauana de Souza Amaral [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Community Health Workers |
|---|
| doi: |
10.1590/1518-8345.6107.3765 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ081291558 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ081291558 | ||
| 003 | DE-627 | ||
| 005 | 20230503072953.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230310s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1590/1518-8345.6107.3765 |2 doi | |
| 035 | |a (DE-627)DOAJ081291558 | ||
| 035 | |a (DE-599)DOAJ23e2c80ef9c349c3a4a815d4f9de8f73 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a spa |a por | ||
| 050 | 0 | |a RT1-120 | |
| 100 | 0 | |a Tauana de Souza Amaral |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Serological and vaccine evaluation for hepatitis B among Community Health Workers |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Objective: to identify the vaccination and serological status against hepatitis B among community health workers; to vaccinate against hepatitis B virus and to evaluate the immune response of susceptible workers. Method: phase I, cross-sectional and descriptive study, among community health workers in a capital city of the Midwest region, through a self-administered questionnaire, checking of vaccination cards, and blood collection for testing of serological markers for hepatitis B. Phase II, cohort study carried out in vaccinated non-immune workers identified in phase I. They received one dose of vaccine (challenge dose) and serological testing. Results: a total of 109 workers participated in the study. Most had vaccination record (97; 89.0%) and vaccination completeness (75; 77.3%), while the isolated anti-HBs (Antibodies against hepatitis B virus) marker was detected in 78 (71.6%) workers. The prevalence of hepatitis B virus exposure was 8.2%. Of the ten non-immune vaccinated workers, after challenge dose, one remained susceptible. Conclusion: although most workers are vaccinated and show immunological response to hepatitis B, susceptibility after challenge dose was identified. Therefore, it is necessary to have a surveillance program of the vaccination situation and serological status for this virus, to promote these workers’ safety. | ||
| 650 | 4 | |a Community Health Workers | |
| 650 | 4 | |a Hepatitis B | |
| 650 | 4 | |a Hepatitis B Antibodies | |
| 650 | 4 | |a Vaccination | |
| 650 | 4 | |a Occupational Health | |
| 650 | 4 | |a Occupational Exposure | |
| 653 | 0 | |a Nursing | |
| 700 | 0 | |a Clery Mariano da Silva Alves |e verfasserin |4 aut | |
| 700 | 0 | |a Fabiana Ribeiro Rezende |e verfasserin |4 aut | |
| 700 | 0 | |a Karlla Antonieta Amorim Caetano |e verfasserin |4 aut | |
| 700 | 0 | |a Anaclara Ferreira Veiga Tipple |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Revista Latino-Americana de Enfermagem |d Universidade de São Paulo, 2004 |g 31(2023) |w (DE-627)DOAJ000127175 |x 15188345 |7 nnns |
| 773 | 1 | 8 | |g volume:31 |g year:2023 |
| 856 | 4 | 0 | |u https://doi.org/10.1590/1518-8345.6107.3765 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/23e2c80ef9c349c3a4a815d4f9de8f73 |z kostenfrei |
| 856 | 4 | 0 | |u http://revodonto.bvsalud.org/scielo.php?script=sci_arttext&pid=S0104-11692023000100305&lng=en&tlng=en |z kostenfrei |
| 856 | 4 | 0 | |u http://revodonto.bvsalud.org/pdf/rlae/v31/1518-8345-rlae-31-e3765.pdf |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1518-8345 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 31 |j 2023 | ||